Zenas Biopharma, INC. (ZBIO) — 8-K Filings

8-K Filings (13)

• Zenas BioPharma Announces Board and Executive Changes — Dec 15, 2025 Risk: medium
  Zenas BioPharma, Inc. announced on December 10, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departur
• Zenas BioPharma Files 8-K on Financials — Nov 12, 2025 Risk: low
  Zenas BioPharma, Inc. filed an 8-K on November 12, 2025, reporting on its results of operations and financial condition. The filing includes financial statement
• Zenas BioPharma Files 8-K Report — Oct 27, 2025 Risk: low
  On October 27, 2025, Zenas BioPharma, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a R
• Zenas BioPharma Files 8-K: Agreements, Financials, Equity Sales — Oct 8, 2025 Risk: medium
  On October 7, 2025, Zenas BioPharma, Inc. entered into a material definitive agreement. The company also reported on its results of operations and financial con
• Zenas BioPharma Completes Asset Acquisition from 03 Life Sciences — Sep 2, 2025 Risk: medium
  On September 2, 2025, Zenas BioPharma, Inc. announced the completion of its acquisition of certain assets from 03 Life Sciences. This transaction involved a mat
• Zenas BioPharma Files 8-K on Financials — Aug 12, 2025 Risk: low
  Zenas BioPharma, Inc. filed an 8-K on August 12, 2025, reporting on its results of operations and financial condition. The filing also includes financial statem
• Zenas BioPharma Announces Board and Executive Changes — Jun 12, 2025 Risk: medium
  Zenas BioPharma, Inc. announced on June 10, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of
• Zenas BioPharma Files 8-K Report — Jun 4, 2025 Risk: low
  On June 4, 2025, Zenas BioPharma, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No spe
• Zenas BioPharma Files 8-K on Operations and Financials — May 15, 2025 Risk: low
  On May 15, 2025, Zenas BioPharma, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well a
• Zenas BioPharma Files 8-K on Financials — Feb 5, 2025 Risk: low
  Zenas BioPharma, Inc. filed an 8-K on February 5, 2025, reporting on its results of operations and financial condition. The filing includes financial statements
• Zenas BioPharma Files 8-K — Dec 2, 2024 Risk: low
  Zenas BioPharma, Inc. filed an 8-K on December 2, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
• Zenas BioPharma Files 8-K on Operations and Financials — Nov 12, 2024 Risk: low
  Zenas BioPharma, Inc. filed an 8-K on November 12, 2024, reporting on its results of operations and financial condition. The filing also includes financial stat
• Zenas BioPharma Files 8-K for Bylaws and Financials — Sep 16, 2024 Risk: low
  Zenas BioPharma, Inc. filed an 8-K on September 16, 2024, reporting amendments to its articles of incorporation or bylaws and financial statements. The company,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX